22 OCTOBER 2026 ASX RELEASE AMPLIA RECEIVES R&D TAX REBATE TOTALLING $4.78 MILLION Melbourne, Australia: Amplia Therapeutics Limited (ASX: ATX), (“Amplia” or the “Company”) is pleased to advise that it has received A$4,778,235.52 via the Research and Development Tax Incentive from the...